Biomarkers in lung cancer screening: the importance of study design
David Baldwin, Matthew Callister, Philip Crosbie, Emma O’Dowd, Robert C. Rintoul, Hilary A. Robbins, R. Steele
Abstract
<b>Use of biomarkers to select participants for lung cancer CT screening could improve clinical and cost effectiveness. It is crucial to design research that evaluates biomarkers against LDCT and to test them in the population in which they will be used.</b>https://bit.ly/3gPHAPu
Topics & Concepts
MedicineLung cancerLung cancer screeningBiomarkerOncologyCancerPopulationMedical physicsInternal medicineIntensive care medicineBiologyEnvironmental healthBiochemistryLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingCancer Genomics and Diagnostics